Triple-negative breast cancer (TNBC), one subtype of breast cancer, lacks estrogen receptor (ER), progesterone receptor (PR), and expresses low levels of human epidermal growth factor receptor 2 (HER-2) and accounts for approximately 15–20% of all breast carcinomas [3–5]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.